Bayer Vietnam leads advances in management of peripheral artery disease
Bayer Vietnam leads advances in management of peripheral artery disease 15:27 | 13/01/2021 With new progress in the management in peripheral artery disease (PAD), Bayer has introduced the new indication of non-Vitamin K antagonist anticoagulant (NOAC) as an effective treatment for PAD patients in Vietnam. MD. MBA Tran Thi Lan Huong, Medical Director at Bayer Vietnam delivered welcome remarks at the hybrid medical scientific event âNew Progress in the Management of Peripheral Artery Diseaseâ On this occasion, Bayer has collaborated with Bach Mai Hospit...
Source: vir.com.vn